Statins and HIV medication: a view from primary care
- 1Research Department of Primary Care and Population Health, Royal Free Campus, University College London, London, UK
- 2King's College, London and Bromley PCT, London, UK
- 3Wessex Deanery, Winchester, Hampshire, UK
- Correspondence to Dr Surinder Singh, Senior Clinical Lecturer, Research Department of Primary Care & Population Health, UCL Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK; s.singh2{at}ucl.ac.uk
-
Contributors SS was involved in the concept and design of the study. EJKP and RK were involved in data collection. All the authors reviewed the manuscript.
- Accepted 8 September 2011
- Published Online First 6 October 2011
- Primary care
- HIV
- statins
- antiretroviral therapy
- drug-drug interactions
- general practice
- clinical care
- qualitative research
- ethics
- adolescent
- Africa
- AIDS
- HIV clinical care
- anteretroviral therapy
- clinical STI care
- compex interventions
Recently, there has been renewed interest in the prescribing of statins to patients receiving antiretroviral therapy.1 2 Primary care is becoming increasingly involved for patients with HIV infection3—not before time, some would argue.4 As reported elsewhere5 from this practice, there is a sizeable cohort of patients in South East London, so we undertook a small-scale audit studyi to explore:
-
the drugs being prescribed to patients in need …
